Virological Outcomes of EVG/COBI/FTC/TDF and EVG/COBI/FTC/TAF in Antiretroviral-Naive HIV-1-Infected Participants with Baseline HIV-1 RNA ≥1,000,000 Copies/ml: A Post Hoc Analysis of Phase III Clinical Trials
暂无分享,去创建一个
K. White | P. Sax | M. Das | C. Cohen | D. Wohl | E. Dejesus | E. Quirk | M. Rhee | C. Callebaut | D. Piontkowsky | Hui Wang | Damian McColl | Jennifer Demorin